文摘
摘要目的:研究影响因素机械血栓切除术(MT)访问在全球的国家,估计太运营商和中心的数量需要无论是满足的差距。
背景:太是一个高度有效的治疗对于大血管闭塞(LVO)中风。在全球层面,太访问之间的差距并没有被研究过。
设计/方法:电子调查是分发给75 MT2020 +区域委员会。太访问被定义为的比例估计LVO病人接受。基于一个假设的一个最优太卷/运营商50和最优太卷/中心150,我们定义以下指标:最优太运营商指数[(一个太运营商/ LVO)的最优数量的1/50××100 = 100 = 2]和最优太中心指数[(一个太中心/最优数量的LVO)×100 = 1/150×100 = 0.67)。当前太中心和运营商指数被计算为每个国家[(当前的数量太运营商或中心/最佳LVO)×100]。
结果:完整的反应(702)从59个国家进行了分析。太访问中值为2.76%(差0.66到14.70)。之间有显著差异太访问国家分组的人均国民总收入(GNI)。在多元回归模型,太访问与国家的人均GNI (:−1.97, 95% CI 2.70−−1.24, P < 0.001),报销(0.69,可信区间0.19 - 1.19,P = 0.008),太运营商指数(:0.85%可信区间0.30到1.39,P = 0.003)和太中心指数(CI−0.96到3.06:2.01,P < 0.001)。中国和印度最大的绝对太中心和运营商差距。
结论:太访问低全球与国家之间巨大的差距。访问的决定因素是国家的人均GNI,获得补偿,他们太运营商和中心指数。
披露:阿西夫博士没有披露。Herial博士没有披露。Otite博士没有披露。德赛医生没有披露。奥尔特加古铁雷斯博士已经收到个人薪酬在10000 - 49999美元的范围为stryker担任顾问。奥尔特加古铁雷斯博士已经收到个人薪酬在5000 - 9999美元的范围为美敦力公司担任顾问。奥尔特加古铁雷斯博士已经收到个人补偿的范围0 - 499美元作为军官或SVIN董事会的成员。奥尔特加古铁雷斯博士的机构已经接到stryker研究支持。奥尔特加古铁雷斯博士的机构收到西门子的研究支持。奥尔特加古铁雷斯博士的机构已经接到IschemiaView研究支持。 The institution of Dr. Ortega Gutierrez has received research support from Medtronic. Dr. Dmytriw has nothing to disclose. Dr. Al-Mufti has nothing to disclose. Dr. Khandelwal has nothing to disclose. Mr. Galav has nothing to disclose. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Castonguay has nothing to disclose. Dr. Potter-Vig has nothing to disclose. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView. Dr. Limaye has nothing to disclose. Dr. Masoud has nothing to disclose. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid Medical. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSave. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
